Previous studies have demonstrated that patients with PAD and CAD have elevated levels of PTX3 [106], and PTX3 can predict both all-cause mortality and cardiovascular mortality in patients with chronic kidney disease [107]. The gene discussed is PTX3; the disease is peripheral arterial disease.